Strategic partnerships Avanti Research actively expands through collaborations, notably with NovoArc GmbH in 2026, signaling opportunities to approach Croda's ecosystem for co-development and joint product ventures in advanced lipid technologies.

Lipid technology focus The company’s emphasis on Avanti lipids and lipid-based delivery systems positions it well for outreach to pharmaceutical and biotech firms seeking lipid encapsulation, formulation, and delivery solutions for RNA therapies and targeted drug delivery.

Acquisition lineage As part of Croda’s portfolio through Avanti Polar Lipids, there is a track record of large-scale strategic acquisitions and integrations, suggesting readiness for enterprise collaborations, licensing deals, or technology transfer opportunities with scale advantages.

Mid-market potential With revenue in the mid-range and a 51-200 employee base, Avanti Research represents a growing yet approachable account for mid-market pharma, CROs, and academic collaborations seeking specialized biochemistry research tools.

Innovation ecosystem The brand aligns with a broader smart science purpose and has a tech stack oriented toward developer-friendly, web-enabled tools and analytics, offering upsell possibilities for digital research platforms, data integration, and efficiency-enhancing tools.